Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cazi Química Farmacêutica is a prominent Brazilian pharmaceutical company established in 1974 and headquartered in Jandira, São Paulo. The company specializes in the development, production, and commercialization of a diverse range of medications, including branded generics and over-the-counter (OTC) products for the domestic market. Its extensive portfolio covers key therapeutic areas such as pain management, infectious diseases, respiratory health, and nutrition, with well-known brands like Aceticil and Albistin. Operating as a 100% national entity, Cazi maintains modern manufacturing facilities that adhere to Good Manufacturing Practices (GMP) to provide accessible healthcare solutions throughout Brazil.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cazi Biosciences.